Skip to Content
Merck
CN
  • [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].

[New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].

Voprosy virusologii (2011-05-07)
V A Shibnev, T M Garayev, M P Finogenova, E S Shevchenko, E I Burtseva
ABSTRACT

The amino acid and peptide derivatives of 1-adamantane carboxylic acid and rimantadine (18 compounds) have been first synthesized and investigated for their activity against influenza A virus (H1N1, H1N1v). In a series of obtained adamantine derivatives, some compounds have been found to be able to inhibit rimantadine-resistant influenza A virus strains. Thus, the antiviral properties of rimantadine can be restored.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Adamantanecarboxylic acid, 99%